Cargando…
HCV genotype-3a T cell immunity: specificity, function and impact of therapy
BACKGROUND: Hepatitis C virus (HCV) genotype-3a infection is now the dominant strain in South Asia and the UK. Characteristic features include a favourable response to therapy; the reasons for this are unknown but may include distinct genotype-3a-specific T cell immunity. In contrast to genotype-1 i...
Autores principales: | Humphreys, Isla S, von Delft, Annette, Brown, Anthony, Hibbert, Linda, Collier, Jane D, Foster, Graham R, Rahman, Monira, Christian, Annabel, Klenerman, Paul, Barnes, Eleanor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733295/ https://www.ncbi.nlm.nih.gov/pubmed/22337948 http://dx.doi.org/10.1136/gutjnl-2011-300650 |
Ejemplares similares
-
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design
por: von Delft, Annette, et al.
Publicado: (2016) -
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
por: von Delft, Annette, et al.
Publicado: (2018) -
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
por: Messina, Jane P, et al.
Publicado: (2015) -
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
por: Swadling, Leo, et al.
Publicado: (2016) -
Ever closer to a prophylactic vaccine for HCV
por: Swadling, Leo, et al.
Publicado: (2013)